Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy
Chasen, Martin, Urban, Laszlo, Schnadig, Ian, Rapoport, Bernardo, Powers, Dan, Arora, Sujata, Navari, Rudolph, Schwartzberg, Lee, Gridelli, CesareVolume:
25
Language:
english
Journal:
Supportive Care in Cancer
DOI:
10.1007/s00520-016-3388-7
Date:
January, 2017
File:
PDF, 459 KB
english, 2017